Chengdu Senkicel Biotechnology Co. Ltd, Chengdu, China.
Stem Cell Res Ther. 2024 Sep 29;15(1):337. doi: 10.1186/s13287-024-03954-3.
Mesenchymal stem cells (MSCs) are a type of cell capable of regulating the immune system, as well as exhibiting self-renewal and multi-lineage differentiation potential. Mesenchymal stem cells have emerged as an essential source of seed cells for therapeutic cell therapy. It is crucial to cryopreserve MSCs in liquid nitrogen prior to clinical application while preserving their functionality. Furthermore, efficient cryopreservation greatly enhances MSCs' potential in a range of biological domains. Nevertheless, there are several limits on the MSC cryopreservation methods now in use, necessitating thorough biosafety assessments before utilizing cryopreserved MSCs. Therefore, in order to improve the effectiveness of cryopreserved MSCs in clinical stem cell treatment procedures, new technological techniques must be developed immediately. The study offers an exhaustive analysis of the state-of-the-art MSC cryopreservation techniques, their effects on MSCs, and the difficulties encountered when using cryopreserved MSCs in clinical applications.
间充质干细胞(MSCs)是一种能够调节免疫系统的细胞,同时具有自我更新和多谱系分化潜能。间充质干细胞已成为治疗性细胞治疗的重要种子细胞来源。在临床应用前,将 MSCs 保存在液氮中以保持其功能至关重要。此外,高效的冷冻保存极大地提高了 MSCs 在多个生物学领域的潜力。然而,目前使用的 MSC 冷冻保存方法存在一些局限性,因此在使用冷冻保存的 MSCs 之前需要进行彻底的生物安全性评估。因此,为了提高冷冻保存的 MSCs 在临床干细胞治疗中的有效性,必须立即开发新的技术手段。本研究对最先进的 MSCs 冷冻保存技术、它们对 MSCs 的影响以及在临床应用中使用冷冻保存的 MSCs 时遇到的困难进行了全面分析。